Optometrists in Casco, MI Accepting Medicare
3 Optometrists found. Showing 1 - 3
 Ms. Lindsey Ellicott-gasta, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3443 County Line Rd, Casco, MI 48064 Phone: 586-727-8000 Fax: 586-727-8004 |
 St Clair Eye Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 3443 County Line Rd, Casco, MI 48064 Phone: 586-727-8000 Fax: 586-727-8000 |
Liesl Anne Caister, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3443 County Line Rd, Casco, MI 48064 Phone: 586-727-8000 Fax: 586-727-8004 |
News Archive
Thousands of men to trial new home test kit for prostate cancer
Thousands of men worldwide are to receive a home test kit for prostate cancer – thanks to pioneering research from the University of East Anglia and the Norfolk and Norwich University Hospital (NNUH).
Confirmation of what we all suspected, electronic gaming is making kids fat
A new study adds to the evidence that sedentary behaviors are linked to childhood obesity and sheds light on the world-wide dimension of the problem.
Caltech biologists show that microRNA-146a protects stem cells during inflammation
When infections occur in the body, stem cells in the blood often jump into action by multiplying and differentiating into mature immune cells that can fight off illness. But repeated infections and inflammation can deplete these cell populations, potentially leading to the development of serious blood conditions such as cancer.
Researchers study how to reduce health risks in infants
Some partnerships were meant to be, and it would be difficult to imagine a more perfect one than June Cho, PhD, RN, and Wally A. Carlo, MD. An assistant professor of nursing in the University of Alabama at Birmingham School of Nursing, Cho sought out Carlo when she first came to UAB in 2008.
FDA approves BioVex' design of a Phase III clinical trial to evaluate OncoVEX
BioVex Inc, a biotechnology company developing clinical stage treatments for cancer and the prevention of infectious disease, announced today that the U.S. Food and Drug Administration (FDA) has approved the design of a single, pivotal, Phase III clinical trial evaluating its lead product, OncoVEX (GM-CSF), for the first-line treatment of patients with squamous cell cancer of the head and neck.
› Verified 6 days ago